Showing 161 - 180 results of 75,094 for search '(( significant ocean based ) OR ( significant ((gap decrease) OR (a decrease)) ))', query time: 0.86s Refine Results
  1. 161
  2. 162
  3. 163

    Synaptopathy at IHC-SGN synapses decreases the peak of the CAP significantly, without changes to peak latency and width. by Maral Budak (6680351)

    Published 2021
    “…<p>(A) Sound-evoked CAPs of SGN fiber populations with different synaptopathy scenarios at 70dB SPL, averaged over 50 simulations. …”
  4. 164
  5. 165
  6. 166

    The effects of <i>in-vitro</i> pH decrease on the gametogenesis of the red tree coral, <i>Primnoa pacifica</i> by Ashley M. Rossin (6611918)

    Published 2019
    “…There was a laboratory effect observed in all measurement types, however this only significantly affected the analyses of spermatogenesis. …”
  7. 167
  8. 168
  9. 169

    Podocyte specific KO of FcRn results in a significant decrease in albuminuria, glomerulosclerosis, and glomerular crescents after nephrotoxic serum nephritis induction. by James F. Dylewski (9922380)

    Published 2020
    “…Podocyte-specific KO of FcRn results in a significant decrease in the number of crescents (p = 0.0007).…”
  10. 170

    Podocyte specific KO of FcRn results in a significant decrease in glomerular crescents 8 days after anti-GBM disease induction. by James F. Dylewski (9922380)

    Published 2020
    “…Podocyte-specific KO of FcRn results in a significant decrease in the number of crescents (a, p = 0.035).…”
  11. 171
  12. 172
  13. 173

    CircAGFG1 absence decreases PKM2 expression to enhance oxaliplatin sensitivity in colorectal cancer in a miR-7-5p-dependent manner by Jun Chen (4238)

    Published 2023
    “…The effect of circAGFG1 on L-OHP sensitivity <i>in vivo</i> was further evaluated by a xenograft model assay. CircAGFG1 and PKM2 expression were significantly increased, while miR-7-5p was decreased in L-OHP-resistant CRC tissues and cells. …”
  14. 174
  15. 175

    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
  16. 176

    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
  17. 177

    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
  18. 178

    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
  19. 179

    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
  20. 180

    Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”